Date of Award
Master of Science (MS)
Fibrocystic breast changes, also known as benign breast disease (BBD) can occur in as many as 50-60% of all women. Certain types of BBD have been shown to increase the risk of developing future breast cancer. As primaty health care providers, nurse practitioners should be knowledgeable of which conditions place a woman at higher risk in order to provide the best possible care and treatment. These women may have increased anxiety that they will develop breast cancer, since they could be at higher risk than a woman without BBD. Health care providers may not be aware of the current evidenced-based recommendations for proper surveillance of patients with benign breast conditions; thus a review of the current literature and clinical decision models will update clinicians on ctment practices. Further, the diagnostic tests associated with screening for breast cancer (such as mammography, ultrasound, and biopsy) may be costly, so determining appropriate intervals of screening for each type of BBD is critical to control health care costs and avoid unnecessary testing
This project included a literature review of current risk models, clinical evaluation tools, and surveillance practices that are used to determine health care management in women with benign breast diseases. The information was summarized into a manuscript accompanied by a post-test and was submitted to The American Journal for Nurse Practitioners (NPs). The purpose of this project was to update the NP's knowledge base of this clinical phenomenon by sharing evidence-based practice and ultimately helping to improve the health care management in women with benign breast diseases
Lee, Erin E., "Determining Evidence Based Managment of Benign Diseases" (2008). Theses and Dissertations. 4688.